Refine by
Vascular Endothelial Growth Factor Equipment & Supplies
136 equipment items found
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
Oglufanide is a naturally occurring thymic immunomodulator,and inhibits vascular endothelial growth factor ...
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 ...
by:F. Hoffmann-La Roche Ltd. based inBasel, SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tivozanib (AV-951; KRN951) is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib exhibits antitumor ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2). Ansornitinib can be used as an antifibrotic agent in lung, liver, kidney, and gastrointestinal fibrotic ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tivozanib hydrochloride hydrate is the hydrate hydrochloride form of Tivozanib (HY-10977). Tivozanib hydrochloride hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrochloride hydrate exhibits antitumor ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tivozanib hydrate (AV-951 hydrate; KRN951 hydrate) is the hydrate form of Tivozanib (HY-10977). Tivozanib hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrate exhibits antitumor ...
Manufactured by:Newcells Biotech Limited based inNewcastle Upon Tyne, UNITED KINGDOM
RPE characterisation includes: morphology assessment, pigmentation, RPE-specific expression at the protein level (BEST1, TYRP1), the analysis of phagocytosis of photoreceptor outer segments, trans-epithelial resistance (TEER), polarity of apical Pigment Epithelium-Derived Factors (PEDF) and basal vascular endothelial growth ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Chloramphenicol is an orally active, potent and broad-spectrum antibiotic. Chloramphenicol shows antibacterial activity. Chloramphenicol represses the oxygen-labile transcription factor and hypoxia inducible factor-1 alpha (HIF-1α) in hypoxic A549 and H1299 cells. Chloramphenicol suppresses the mRNA levels of vascular endothelial ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES104 is a bispecific antibody that simultaneously blocks Delta-like ligand 4/Notch (DLL4) and vascular endothelial growth factor A (VEGF-A) signaling pathways, which are critical to angiogenesis and tumor vascularization. VEGF also plays an important role in creating an immune suppressive TME. Pre-clinical and ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
FOTIVDA (tivozanib) is an oral, once-daily, differentiated vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI). It is a potent, selective inhibitor of VEGFRs 1, 2, and 3 with a long half-life designed to improve efficacy and tolerability.1,2 AVEO received U.S. Food and Drug Administration (FDA) ...
Manufactured by:EirGenix, Inc based inNew Taipei City, TAIWAN
Product: EG12021 Bevacizumab Biosimilar. Indication: Cancer. Target: VEGF. Status: ...
Manufactured by:Stempeutics Research Pvt. Ltd. based inBangalore, INDIA
An under-eye dark circle reduction serum prepared from the bio-active medium of stem cells that reduces under eye dark circles, rehydrates and soothes the ...
Manufactured by:Stempeutics Research Pvt. Ltd. based inBangalore, INDIA
A hair serum prepared from the bio-active medium of stem cells that promotes scalp hair growth and reduces hair ...
Manufactured by:Ampersand Biosciences based inLake Clear, NEW YORK (USA)
Hamster Cytokine Panel 1 detects 9 cytokines and growth factors (IL-2, IL-4, IL-6, IFNγ, MCP-1, MIP-1α, TNFα & VEGF) in a pre-mixed multiplex assay, developed and validated for the Luminex ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Age-related macular degeneration (AMD) is a painless eye condition that leads to the gradual loss of central vision and is the most common cause of sight loss in the developed world and the third most common globally. Around 600,000 people in the UK currently have sight loss caused by AMD and around 70,000 new cases are diagnosed every year. Macular degeneration develops when the macula (the part ...
Manufactured by:Stempeutics Research Pvt. Ltd. based inBangalore, INDIA
A novel anti-ageing serum with stem cell derived bioactive factors which promote firm, well moisturized and brighter skin with reduced blemishes and fine ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
HLX04-O, recombinant anti-VEGF humanised monoclonal antibody injection. It is indicated for wet age-related macular degeneration (wAMD). HLX04-O was granted Phase 3 clinical study approvals in Australia, the United States, Singapore and the EU countries such as Latvia, Hungary and Spanish. In April 2022, the first patient in Australia and Latvia was dosed in the global multicentre phase 3 ...
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
Olinvacimab is an anti-angiogenic antibody that neutralizes the VEGF/VEGFR2 pathway, thus inhibiting tumor growth and ...